This area of our website is for healthcare professionals only

Please click below to declare your professional status:

YES, I am a healthcare professional  NO, I am not a healthcare professional

Guidelines and policies

Find useful guidelines and policies for professionals working with lipid conditions


ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019): The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Source: European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Northern England Evaluation & Lipid Intensification Guideline

Low density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic and clinical studies.  A consensus statement from the European Atherosclerosis Society Panel
Source: European Heart Journal 

Joint British Societies for the Prevention of Cardiovascular Disease (2014) Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3) 
Source: JBS3

National Institute for Health and Care Excellence (2014) Cardiovascular disease: risk assessment and reduction, including lipid modification
Source: NICE

Scottish Intercollegiate Guidelines Network (SIGN) Risk estimation and the prevention of cardiovascular disease.
Source: SIGN

Public Health England (2014) Adult obesity and type 2 diabetes.
Source: PHE

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement (2022).
Source: European Atherosclerosis Society

Read our Heart UK Statements of Care